EQT (NYSE:EQT) has been analyzed by 13 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary of their ...

Debt Management: EQT's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.41. The Significance of Analyst Ratings Explained.

Below is Validea's guru fundamental report for EQT CORP (EQT). Of the 22 guru strategies we follow, EQT rates highest using our Growth Investor model based on the published strategy of Martin Zweig.

STOCKHOLM--EQT has set the target size for its EQT XI fund at 23 billion euros ($26.57 billion). The Swedish buyout group said Sunday that the actual fund size is dependent on the outcome of the ...

EQT Press Office, [email protected], +46 8 506 55 334. The information contained herein does not constitute an offer to sell, nor a solicitation of an offer to buy, ...

EQT Stock Up 2.3%. Shares of EQT stock opened at $56.82 on Friday. The company has a quick ratio of 0.51, a current ratio of 0.70 and a debt-to-equity ratio of 0.37. EQT Co. has a 12 month low of ...

Average Target Price for EQT Suggests Upside. Based on short-term price targets offered by 21 analysts, the Zacks average price target is $60.14 per share. The average suggests an 11.4% upside from ...

Acumatica CEO John Case outlines growth plans after Vista Equity acquisition, including team expansion and product investment in new verticals.

STOCKHOLM, June 9, 2025 /PRNewswire/ -- EQT Life Sciences is pleased to announce that the LSP 7 fund has invested in Mosanna Therapeutics ("the Company").